Search
MeiraGTx Holdings PLC
MGTXAdd to Watchlist
11.790USD
-0.190-1.59%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.09BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of MeiraGTx Holdings PLC is 8.50, ranking 108 out of 385 in the Biotechnology & Medical Research industry. The average price target is 27.00, with a high of 50.00 and a low of 15.00.
Analyst Rating
Based on
7
analysts
Buy
Current Rating
29.286
Target Price
+148.39%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
MeiraGTx Holdings PLC
MGTX
7
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is MeiraGTx Holdings PLC's expected revenue for the next quarter?
MeiraGTx Holdings PLC's expected revenue is 12.48M.
What is MeiraGTx Holdings PLC's price target?
Analysts forecast that MeiraGTx Holdings PLC's price target is USD 27.00, with the highest forecast at USD 50.00 and the lowest forecast at USD 15.00.
How have MeiraGTx Holdings PLCMGTX's recent earnings per share performed?
The market expectation was USD -0.57, while MeiraGTx Holdings PLCMGTX's earnings per share (EPS) for the previous quarter was USD 0.19. EPS for the next quarter is expected at USD -0.46.
What is the analyst rating for MeiraGTx Holdings PLC?
Based on the ratings of MeiraGTx Holdings PLC's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.